Policy & Medicine September 8, 2024
Thomas Sullivan

James Comer, Chairman of the United States House Committee on Oversight and Accountability, called on CEOs of three pharmacy benefit managers (PBMs) to correct the record for statements made during their appearances at a recent House Oversight Committee hearing. The three executives – of CVS Caremark, Express Scripts, and OptumRx – testified during a July 23, 2024, hearing, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.”

While present at the hearing, the executives made statements that contradict findings by the House Committee and the Federal Trade Commission about PBMs’ “self-benefitting practices that jeopardize patient care, undermine local pharmacies, and raise prescription drug prices.” For example, in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article